M Kathleen Behrens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from M kathleen behrens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In M Kathleen Behrens Today - Breaking & Trending Today

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $24.55 Consensus Price Target from Brokerages

Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month […] ....

M Kathleen Behrens , Jakob Haldor Topsoe , Robertw Baird , Needham Company , Securities Exchange Commission , Exchange Traded Concepts , Royal Bank , Raymond James Associates , Biosciences Inc , Morgan Stanley , Biosciences Company Profile , Maven Securities , Get Free Report , Director Jakob Haldor Topsoe , Exchange Commission , Directorm Kathleen Behrens , Partners Asset Management , Traded Concepts , Exoduspoint Capital Management , Point Capital Management , Get Free , Digm Biosciences , Nasdaq Igms ,

IGM Biosciences (NASDAQ:IGMS) Price Target Cut to $17.00

IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target reduced by HC Wainwright from $22.00 to $17.00 in a research note issued to investors on Monday, MarketBeat reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for IGM Biosciences’ Q3 2023 earnings at ($1.23) EPS, Q4 2023 earnings […] ....

Nova Scotia , M Kathleen Behrens , Jakob Haldor Topsoe , Robertw Baird , Biosciences Inc , Pricet Rowe Associates Inc , Blackrock Inc , Securities Exchange Commission , Vanguard Group Inc , Royal Bank , Millennium Management , Free Report , Moderate Buy , Get Free Report , Director Jakob Haldor Topsoe , Exchange Commission , Directorm Kathleen Behrens ,

Morgan Stanley Lowers IGM Biosciences (NASDAQ:IGMS) Price Target to $15.00

IGM Biosciences (NASDAQ:IGMS – Get Free Report) had its target price reduced by analysts at Morgan Stanley from $20.00 to $15.00 in a report issued on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective suggests a potential upside of 90.84% from the stock’s previous close. […] ....

Nova Scotia , Jakob Haldor Topsoe , Robertw Baird , M Kathleen Behrens , Pricet Rowe Associates Inc , Securities Exchange Commission , Morgan Stanley , Royal Bank , Biosciences Inc , Blackrock Inc , Needham Company , Millennium Management , Vanguard Group Inc , Get Free Report , Director Jakob Haldor Topsoe , Directorm Kathleen Behrens , Exchange Commission , Digm Biosciences , Nasdaq Igms , Lower Price Target ,

IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Recommendation of "Moderate Buy" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

M Kathleen Behrens , Stifel Nicolaus , Jakob Haldor Topsoe , Morgan Stanley , York Mellon Corp , Swiss National Bank , Td Asset Management Inc , Exchange Traded Concepts , Maven Securities , Royal Bank , Securities Exchange Commission , Igm Biosciences Inc , Biosciences Inc , Get Free Report , Director Jakob Haldor Topsoe , Exchange Commission , Directorm Kathleen Behrens , Management Inc , National Bank , New York Mellon Corp , Get Free ,